drugset / Trial / NCT02486276

The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache

NCT02486276

Completed 30 enrolled Danish Headache Center
RandomizedCrossoverDouble-blindTreatment

Summary

To develop a pragmatic migraine model the investigators will induce headache in healthy volunteers and in patients with migraine without aura with a phosphodiesterase inhibitor (cilostazol). If the headache responds to sumatriptan, the model can be used to test new drug candidates.

Timeline

Start
2015-06
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sumatriptan Unknown 50 mg Oral
Comparator Cilostazol Small molecule 200 mg Oral

Indications